277 related articles for article (PubMed ID: 26381042)
1. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
Hur H; Kim YB; Ham IH; Lee D
J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
3. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.
Hu X; Xin Y; Xiao Y; Zhao J
Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.
Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y
Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
8. High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer.
Yan P; Li YH; Tang ZJ; Shu X; Liu X
Asian Pac J Cancer Prev; 2014; 15(20):8923-9. PubMed ID: 25374230
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma.
Li C; Ji L; Ding ZY; Zhang QD; Huang GR
Tumour Biol; 2013 Apr; 34(2):1021-6. PubMed ID: 23283818
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients.
Wang W; Seeruttun SR; Fang C; Chen J; Li Y; Liu Z; Zhan Y; Li W; Chen Y; Sun X; Li Y; Xu D; Guan Y; Zhou Z
Ann Surg Oncol; 2016 Apr; 23(4):1244-51. PubMed ID: 26620645
[TBL] [Abstract][Full Text] [Related]
12. High SLC17A9 expression correlates with poor survival in gastric carcinoma.
Li J; Su T; Yang L; Deng L; Zhang C; He Y
Future Oncol; 2019 Dec; 15(36):4155-4166. PubMed ID: 31799885
[No Abstract] [Full Text] [Related]
13. Loss of ARID1A expression is associated with poor prognosis in small intestinal carcinoma.
Kim MJ; Gu MJ; Chang HK; Yu E
Histopathology; 2015 Mar; 66(4):508-16. PubMed ID: 25400081
[TBL] [Abstract][Full Text] [Related]
14. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.
Sun X; Sun Z; Zhu Z; Li C; Zhang J; Xu H; Sun M
Tumour Biol; 2015 Sep; 36(10):7521-30. PubMed ID: 25913622
[TBL] [Abstract][Full Text] [Related]
15. Downregulated SASH1 expression indicates poor clinical prognosis in gastric cancer.
Zhou N; Liu C; Wang X; Mao Q; Jin Q; Li P
Hum Pathol; 2018 Apr; 74():83-91. PubMed ID: 29320755
[TBL] [Abstract][Full Text] [Related]
16. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
[TBL] [Abstract][Full Text] [Related]
17. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
[TBL] [Abstract][Full Text] [Related]
18. The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes.
Zheng HC; Zheng YS; Xia P; Xu XY; Xing YN; Takahashi H; Guan YF; Takano Y
Histol Histopathol; 2010 Apr; 25(4):445-52. PubMed ID: 20183797
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of βIII-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer.
Zheng WE; Chen H; Yuan SF; Wu LL; Zhang W; Sun HY; Chen WJ
J BUON; 2012; 17(2):284-90. PubMed ID: 22740207
[TBL] [Abstract][Full Text] [Related]
20. Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma.
Zhang S; He J; Jia Z; Yan Z; Yang J
Urol Oncol; 2018 May; 36(5):243.e9-243.e20. PubMed ID: 29503142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]